HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 13-15, 2025

March 13 -15, 2025 | Rome, Italy

Genetics and Epigenetics

Genetics and Epigenetics

Rare diseases induced by changes in single genes' function can be chronically debilitating and life-threatening. From symptom analysis to molecular aetiology assessment, genomics is driving a fundamental shift in rare disease diagnosis. Understanding the biological foundation of disease can lead to better treatment and care, with predictable, evidence-based outcomes.

Epigenetics is the study of heritable and persistent changes in gene expression caused by chromosomal changes rather than DNA sequence changes. Epigenetic mechanisms can affect gene expression by chemical alterations of DNA bases and changes to the chromosomal superstructure in which DNA is packaged, despite not directly modifying the DNA sequence. Epigenetic mechanisms are a variety of gene-control systems that operate independently of genetic sequences. Epigenetics is the study of a variety of "readers," "writers," and "erasers" who play important roles in development, health, and disease. Epigenetics' role in rare diseases is one of its most essential aspects.

  • Epigenetic Mechanism
  • Genomic Analysis
  • Post-Translational Modifications
  • Clinical Significance
  • Sequencing
  • Gene Discovery
  • Genetic and Genomic Studies
  • Novel Computational Approaches
Committee Members
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Orphan Drugs 2025 Speakers
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Melissa Keenan

Melissa Keenan

La Jolla Labs, United States
Tags

Submit your abstract Today

Watsapp